How should we measure emesis in palliative care?

Abstract

There are many assessment tools available to measure emesis. This Association for Palliative Medicine Science Committee Task Group undertook a review of the validity and suitability of the assessment tools available to measure nausea, vomiting and retching within a palliative care population. Electronic databases were searched from 1970 to 2004. Both specific and global tools were identified and reviewed for their validity, reliability and suitability for our patient population where coexisting cognitive impairment and significant co-morbidities may make accurate assessment of symptoms difficult. Within specific palliative care scenarios namely daily clinical assessment, prevalence surveys and randomized controlled trial settings, the team reached a consensus on which tools had the greatest evidence to recommend them, either for immediate use or for further validation studies. An ideal measurement tool for the assessment of nausea, vomiting and retching has not yet been developed. Palliative Medicine 2007; 21 : 369—383

Keywords

assessment measures cancer nausea palliative care retching vomiting

Get full access to this article

View all access options for this article.

References

Morrow G. The assessment of nausea and vomiting past problems, current issues and suggestions for future research . Cancer 1984; 53: 2267—78 .

Curtis E. , Krech R. , Walsh D. Common symptoms in patients with advanced cancer . J Palliat Care 1991; 7: 25—9 .

Donnelly S. , Walsh D. , Rybicki L. The symptoms of advanced cancer: identification of clinical and research priorities by assessment of prevalence and severity . J Palliat Care 1995; 11: 27—32 .

Fainsinger R. , Miller MJ , Bruera E. , Hanson J. , Maceachern T. Symptom control during the last week of life on a palliative care unit . J Palliat Care 1991; 7: 5—11 .

Tonato M. , Roila F. , Del Favero A. Nausea in anti-cancer therapy: measurement and mechanisms. In Andrews PLR eds. Emesis in anti-cancer therapy: mechanisms and treatment, Chapman and Hall, London , 1993: 61—70.

Rhodes V. , Mc Daniel R. Nausea, vomiting and retching: complex problems in palliative care . CA Cancer J Clin 2001; 51: 232—48 .

Morrow G. Methodology and assessment in clinical antiemetic research; a meta analysis of outcome parameters . Br J Cancer Suppl 1992 ; 66: S38—S41 .

Rhodes VA , Watson PM , Johnson MH Development of reliable and valid measures of nausea and vomiting . Cancer Nurs 1984; 7: 33—41 .

Chapko M. , Syrjala K. , Bush N. , Jedlow C. , Yanke M. Development of a behavioural measure of mouth pain, nausea and wellness for patients receiving radiation and chemotherapy . J Pain Symptom Manage 1991; 6: 15—23 .

10.

Huskisson EC Measurement of pain . Lancet 1974; 2: 1127—31 .

11.

Del Favero A , Roila F. , Basurto C. Assessment of nausea . Eur J Clin Pharmacol 1990; 38: 115—20 .

12.

Borjeson S. , Hursti T. , Peterson C. , et al. Similarities and differences in assessing nausea on a verbal categorical scale and a visual analogue scale . Cancer Nurs 1997; 20(4): 260—6 .

13.

Kremer E. , Hampton Atkinson J. , Ignelzi RJ Measurement of Pain: Patient preference does not confound pain measurement . Pain 1981;10: 241—8 .

14.

Maguire P. , Selby P. Assessing quality of life in cancer patients . Br J Cancer 1989; 60: 437—40 .

15.

Feinstein AR Critical features of a QOL assessment tool. In Feinstein AR ed. Clinimetrics, Yale University Press, New Haven, CT , 1987: 141—66.

16.

Donnelly S. , Walsh D. Quality of life assessment in advanced cancer . Palliat Med 1996; 10: 275—83 .

17.

Selby P. , Robertson B. Measurement of quality of life in patients with cancer . Cancer Surv 1987; 6: 522—43 .

18.

Chang VT , Hwang S. , Feuerman M. Validation of the Edmonton symptom assessment . Cancer 2000; 88(9): 2164—71 .

19.

McMillan S. , Weitzner M. Quality of life in cancer patients use of a revised hospice index . Cancer Pract 1998 ; 6: 282—8 .

20.

MacAdam DB , Smith M. An initial assessment of suffering in terminal illness . Palliat Med 1987; 1: 37—47 .

21.

Ellershaw JE Assessing the effectiveness of a hospital palliative care team . Palliat Med 1995; 9: 145—52 .

22.

Steel K. , Ljunggren G. , Topinkova E. , et al. The RAI-PC: An assessment instrument for palliative care in all settings . Am J Hosp Palliat Care 2003; 20(3): 211—9 .

23.

Sterkenburg C. , King B. , Woodward C. A reliability and validity study of the McMaster quality of life scale (MQLS) for a palliative population . J Palliat Care 1996; 12: 18—25 .

24.

Samarel N. , Kun Leddy S , Greco K. , et al. Development and testing of the Symptom Experience Scale . J Pain Symptom Manage 1996; 12: 221—8 .

25.

Padilla G. Validity of health-related quality of life subscales . Prog Cardiovasc Nurs 1992; 7: 13—20 .

26.

Portenoy RK , Thaler HT , Kornblith AB , et al. The memorial symptom assessment scale: an instrument for the evaluation of symptom prevalence, characteristics and distress . Eur J Cancer 1994; 30(9): 1326—36 .

27.

Rhodes V. , Mc Daniel R. , Homan S. , et al. An instrument to measure symptom experience: symptom occurrence and symptom distress . Cancer Nurs 2000; 23: 49—54 .

28.

Aaronson NK , Ahmedzai S. , Bergman B. , et al. The European Organisation for research and treatment of Cancer QLQ-C30: A Quality of life instrument for use in International clinical trials in Oncology . J Natl Cancer Inst 1993; 85: 365—76 .

29.

Stein K. , Denniston M. , Baker F. , et al. Validation of a modified rotterdam symptom checklist for use with cancer patients in the United States . J Pain Symptom Manage 2003; 26: 975—89 .

30.

Watson M. , Law M. , Maguire GP , Robertson B. , Greer S. , Bliss JM , Ibbotson T. Further development of a quality of life measure for cancer patients: the Rotterdam Symptom Checklist (revised) . Psychooncology 1992; 1: 35—44 .

31.

Horton R. Differences in assessment of symptoms and quality of life between patients with advanced cancer and their specialist palliative care nurses in a home care setting . Palliat Med 2002; 16: 488—94 .

32.

Rathbone GV , Horsley S. , Goacher J. A self-evaluated assessment suitable for seriously ill hospice patients . Palliat Med 1994; 8: 29—34 .

33.

Ahmedzai S. Feasibility of self rating questionnaires for quality of life evaluation in palliative care . Palliat Med 1995; 9: 64—5 .

34.

Caraceni A. , Cherny N. , Fainsinger R. , Kaasa S. , Poulain P. , Radbruch L. , De Conno F. Pain measurement tools and methods in clinical research in palliative care: recommendations of am expert working group of the European association of palliative care . J Pain Symptom Manage 2002; 23: 239—52 .

35.

Rhodes VA , Mc Daniel RW. The index of nausea, vomiting and retching: a new format of the index of nausea and vomiting . Oncol Nurs Forum 1999; 26(5): 889—94 .

36.

Rees E. , Hardy J. The Use of the Edmonton Symptom Assessment scale within a palliative care unit in the UK . Palliat Med 1998; 12: 75—82 .

37.

Hardy JR , Edmonds P. , Turner P. , et al. The use of the Rotterdam Symptom Checklist in Palliative Care . J Pain Symptom Manage 1999; 18: 79—85 .

38.

Cella D. , Perry S. Reliability and concurrent validity of three visual-analogue mood scales . Psychol. Rep. 1986; 59: 827—33 .

39.

Bruera E. , Kuehn N. , Miller M. The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients . J Palliat Care 1991; 7(2): 6—9 .

40.

De Conno F. , Caraceni A. , Gamba A. , et al. Pain measurement in cancer patients: a comparison of six methods . Pain 1994; 57: 161—6 .

41.

Jensen M. , Karoly P. , Braver S. The measurement of clinical pain intensity: a comparison of six methods . Pain 1986; 27: 117—26 .

42.

Lindley CM , Hirsch JD , O'Neill CV , Transau MC , Gilbert CS , Osterhaus JT Quality of life consequences of chemotherapy-induced emesis . Qual Life Res 1992; 1: 331—40 .

43.

McCorkle R. , Young K. Development of a symptom distress scale . Cancer Nurs 1978; 1: 373—8 .

44.

Melzack R. Measurement of nausea . J Pain Symptom Manage 1989; 4: 157—60 .

45.

Fetting J. , Grochow L. , Folstein M. , Ettinger D. , Colvin M. The course of nausea and vomiting after high-dose cyclophosphamide . Cancer Treat Rep 1982; 66: 1487—93 .

46.

Bruera E. , Seifert L. , Watanabe S. , et al. Chronic nausea in advanced cancer patients: a retrospective assessment of a metoclopramide-based antiemetic regimen . J Pain Symptom Manage 1996; 11: 147—53 .

47.

Bruera E. , Belzile M. , Neumann C. , et al. A double-blind, crossover study of controlled-release metoclopramide and placebo for the chronic nausea and dyspepsia of advanced cancer . J Pain Symptom Manage 2000; 19: 427—35 .

48.

Braud AC , Genre D. , Leto C. , et al. Nurses repeat measurement of chemotherapy symptoms: feasibility, resulting information, patient satisfaction . Cancer Nurs 2003; 26: 468—75 .

49.

Price D. , Mc Grath P. , Rafii A. , Buckingham B. The validation of visual analogue scales as ratio scale measures for chronic and experimental pain . Pain 1983; 17: 45—56 .

50.

Lewis FM , Firsich SC , Parcell S. Clinical tool development for adult chemotherapy patients: process and content . Cancer Nurs 1979; 2: 99—108 .

51.

Franklin HR , Simonetti PC , Dubbelman AC , et al. Toxicity grading systems . Ann Oncol 1994; 5: 113—7 .

52.

Corli O. , Cozzolino A. , Battaiotto L. Effectiveness of levosulpiride versus metoclopramide for nausea and vomiting in advanced cancer patients: a double-blind randomized, crossover study . J Pain Symptom Manage 1995; 10: 521—26 .

53.

Bruera E. , Moyano J. , Sala R. , et al. Dexamethasone in addition to metoclopramide for chronic nausea in patients with advanced cancer: a randomized controlled trial . J Pain Symptom Manage 2004; 4: 381—7 .

54.

Vainio A. , Auvinen A. , et al. Prevalence of symptoms among patients with advanced cancer: an international collaborative study . J Pain Symptom Manage 1996; 12: 3—10 .

55.

Eisenchlas J. , Garrigue N. , Junin M. , De Simone G. Low-dose levomepromazine in refractory emesis in advanced cancer patients: an open-label study . Palliat Med 2005; 19: 71—5 .

56.

Costello P. , Wiseman J. , Batten B. , Bennett M. Assessing hospice inpatients with pain using numerical rating scales . Palliat Med 2001; 15: 257—8 .

57.

Martin A. , Pearson J. , Cai B. , Elmer M. , Horgan K. , Lindley C. Assessing the impact of nausea and vomiting on patients' daily lives: a modified version of the Functional Living Index-Emesis (FLIE) with 5-day recall . Supp Care Cancer 2003; 11: 522—7 .

58.

Axelsson B. , Sjoden P-O. Quality of life of cancer patients and their spouses in palliative home care . Palliat Med 1998; 12: 29—39 .

59.

Dudgeon D. , Harlos M. , Clinch J. The Edmonton Symptom Assessment Scale (ESAS) as an audit tool . J Palliat Care 1999; 15: 14—9 .

60.

Hjermstad MJ , Fossa SD , Bjordal K. , Kaasa S. Test/retest study of the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire . J Clin Oncol 1995; 13: 1249—54 .

61.

Schipper H. , Clinch J. , McMurray A. , Levitt M. Measuring the quality of life of cancer patients: the Functional Living Index-Cancer; development and validation . J Clin Oncol 1984; 2: 472—83 .

62.

Bosnjak S. , Radulovic S. , Neskovic-Konstantinovic , Mitrovic L. Patient statement of satisfaction with antiemetic treatment is related to quality of life . Am J Clin Oncol 2000; 23: 575—78 .